Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Enseval Putera Megatrading TbkISX:EPMT +3.51%89 Return-on-Tangible-Equity is 13.47% as of Mar. 2026, which is 26% above its 10-year median of 10.70. GuruFocus rates ISX:EPMT with a GF Score™ of 89/100 and a GF Value™ of Rp2,689.14 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 112 Medical Distribution companies, PT Enseval Putera Megatrading Tbk ranks better than 58.04% on this metric.
The historical rank and industry rank for PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity or its related term are showing as below:
ISX:EPMT'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.6 Med: 10.7 Max: 12.81
Current: 10.01
During the past 13 years, PT Enseval Putera Megatrading Tbk's highest Return-on-Tangible-Equity was 12.81%. The lowest was 9.60%. And the median was 10.70%.
ISX:EPMT's Return-on-Tangible-Equity is ranked better than 58.04% of 112
companies
in the Medical Distribution industry
Industry Median: 8.755
vs ISX:EPMT: 10.01
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Enseval Putera Megatrading Tbk Return-on-Tangible-Equity Related Terms
PT Enseval Putera Megatrading Tbk Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:EPMT vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Enseval Putera Megatrading Tbk Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.47% mean?
PT Enseval Putera Megatrading Tbk (ISX:EPMT) has a Return-on-Tangible-Equity of 13.47% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. This is 26% above median its historical median of 10.70. Over the past decade, PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity has ranged from 9.60 to 12.81. According to the industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #47 out of 112 companies in the Medical Distribution industry, placing it in the top 42%.
Is PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity too high?
PT Enseval Putera Megatrading Tbk's current Return-on-Tangible-Equity of 13.47% is 26% above median its 10-year median of 10.70. Over the past 10 years, this metric has ranged from a low of 9.60 to a high of 12.81. The Medical Distribution industry median Return-on-Tangible-Equity is 8.76. PT Enseval Putera Megatrading Tbk's value of 13.47% is 53.9% above this industry median. Based on the distribution chart, PT Enseval Putera Megatrading Tbk ranks #47 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Enseval Putera Megatrading Tbk has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Enseval Putera Megatrading Tbk's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #47 out of 112 companies for Return-on-Tangible-Equity. This puts PT Enseval Putera Megatrading Tbk in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.76. PT Enseval Putera Megatrading Tbk's value of 13.47% is 53.9% above this benchmark. Historically, PT Enseval Putera Megatrading Tbk's own Return-on-Tangible-Equity has ranged from 9.60 to 12.81 over the past decade. While the company's 10-year median is 10.70 vs. the industry median of 8.76, PT Enseval Putera Megatrading Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.76, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Enseval Putera Megatrading Tbk's current Return-on-Tangible-Equity of 13.47% is 53.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Enseval Putera Megatrading Tbk's current Return-on-Tangible-Equity is 13.47%, which is 26% above median its own 10-year median of 10.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Enseval Putera Megatrading Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk (ISX:EPMT) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp2,689.14, compared to a current price of Rp2,360.00 — trading 12.2% below its estimated fair value. The current Return-on-Tangible-Equity is 13.47%, which is 26% above median its 10-year median of 10.70 and 53.9% above the Medical Distribution industry median of 8.76. PT Enseval Putera Megatrading Tbk's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Enseval Putera Megatrading Tbk (ISX:EPMT), the current Return-on-Tangible-Equity is 13.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Enseval Putera Megatrading Tbk (ISX:EPMT) Overvalued in 2026?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk stock appears to be undervalued.
The current stock price of Rp2,360.00 is trading 12.2% below its estimated GF Value™ of Rp2,689.14.
GuruFocus considers PT Enseval Putera Megatrading Tbk to be Modestly Undervalued.
Key valuation signals for ISX:EPMT:
Return-on-Tangible-Equity: 13.47% (26% above median its 10-year median of 10.70)
GF Value™: Rp2,689.14 vs. price of Rp2,360.00 (12.2% below fair value)
Industry Position: 53.9% above the Medical Distribution median (#47 of 112)
No single metric tells the full story. See the ISX:EPMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Enseval Putera Megatrading Tbk is a general distributor dealing in pharmaceutical products, consumer products, and medical devices. The company also acts as an agent and distributor of consumer goods, prescription medicines, non-prescription medicines, raw materials for the pharmaceutical, medical equipment, including marketing activities, veterinary medicines, cosmetics, and other industries. The company's business segments are Pharmaceuticals which generates maximum revenue; Consumer products, and Others.
89GF Score
Get the complete analysis for ISX:EPMT
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:EPMT has been successfully added to your 
